[ad_1]
Regeneron [로이터=연합뉴스 자료사진]
(Seoul = Yonhap News) Reporter Kim Yong-rae = The new antibody treatment for coronavirus infection (Corona 19) from US biotech company Regeneron has been approved for emergency use by the US Food and Drug Administration (FDA).
According to foreign media such as Reuters and Bloomberg on the 21st (local time), the FDA approved the emergency use of Regeneron’s monoclonal antibody treatment “REGN-COV2”.
Unauthorized reproduction-redistribution prohibited>
22/11/2020 10:40 sent
Source link
